Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05492266 · ClinicalTrials.gov registry record · NA
Expiratory Muscle Strength Training for Hypernasal Speech in Children
A NA study of Velopharyngeal Insufficiency and Velopharyngeal Incompetence Due to Cleft Palate, sponsored by Noel Jabbour.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05492266: Recruiting NA study of Velopharyngeal Insufficiency and Velopharyngeal Incompetence Due to Cleft Palate, sponsored by Noel Jabbour.
NCT05492266 is a NA study of Velopharyngeal Insufficiency and Velopharyngeal Incompetence Due to Cleft Palate that is actively recruiting participants, run by Noel Jabbour. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05492266, a NA study of Velopharyngeal Insufficiency and Velopharyngeal Incompetence Due to Cleft Palate, is actively recruiting participants, sponsored by Noel Jabbour.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insufficiency. The purpose of this research study is to test if soft palate exercises using a hand help breathing device will help improve the ability of the soft palate to close the area between the throat and nose and help improve speech.
Primary Outcome
Percent change in nasalance measured during nasometry
Conditions Studied
Interventions
- DEVICE Expiratory Muscle Strength Training
- DEVICE Maintenance Training
Study Locations (1)
Pennsylvania
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2027-11 |
| Phase | NA |
What NCT05492266 shows while recruiting
NCT05492266 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Velopharyngeal Insufficiency appearing as the primary indexed condition, and to 2 interventions - of which Expiratory Muscle Strength Training is the first listed.
NCT05492266 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05492266 about?
NCT05492266 is a clinical study titled "Expiratory Muscle Strength Training for Hypernasal Speech in Children". When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insufficiency. The purpose of this research study is to test if soft palate exercises using a hand help breathing device will help improve the abilit...
What is the current status of trial NCT05492266?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-03. Estimated completion is 2027-11.
What conditions does trial NCT05492266 study?
This clinical trial studies the following conditions: Velopharyngeal Insufficiency, Velopharyngeal Incompetence Due to Cleft Palate, Inadequate Velopharyngeal Closure, Palatopharyngeal Incompetence, Hypernasality.
What interventions are being tested in trial NCT05492266?
The interventions under investigation include: Expiratory Muscle Strength Training (DEVICE), Maintenance Training (DEVICE).
Who is sponsoring clinical trial NCT05492266?
This trial is sponsored by Noel Jabbour, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05492266 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Velopharyngeal Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05492266's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI